<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>FRCS in 15</title>
    <link>https://thamesuro.com/podcast/</link>
    <atom:link href="https://thamesuro.com/podcast/rss.xml" rel="self" type="application/rss+xml"/>
    <language>en-gb</language>
    <copyright>&#169; Thames Uro Limited</copyright>
    <description>The FRCS (Urol) syllabus in bite-sized episodes, one topic at a time, each about fifteen minutes. Written by a urology registrar sitting the exam and grounded in current EAU, NICE and BAUS guidance, so what you hear is what the exam actually rewards. Revise on the commute, on the ward round, or in the last three days before the paper. These episodes are free. The full library of 30+ episodes, the original SBA question bank, the guideline-cited crib sheets and the live AI viva examiner are at thamesuro.com.</description>
    <itunes:summary>The FRCS (Urol) syllabus in bite-sized episodes, one topic at a time, each about fifteen minutes. Written by a urology registrar sitting the exam and grounded in current EAU, NICE and BAUS guidance, so what you hear is what the exam actually rewards. Revise on the commute, on the ward round, or in the last three days before the paper. These episodes are free. The full library of 30+ episodes, the original SBA question bank, the guideline-cited crib sheets and the live AI viva examiner are at thamesuro.com.</itunes:summary>
    <itunes:subtitle>The FRCS (Urol) syllabus, one topic at a time</itunes:subtitle>
    <itunes:author>Thames Uro</itunes:author>
    <itunes:owner>
      <itunes:name>Thames Uro</itunes:name>
      <itunes:email>info@thamesuro.com</itunes:email>
    </itunes:owner>
    <itunes:image href="https://thamesuro.com/podcast/cover.jpg"/>
    <itunes:category text="Health &amp; Fitness">
      <itunes:category text="Medicine"/>
    </itunes:category>
    <itunes:category text="Education"/>
    <itunes:explicit>false</itunes:explicit>
    <itunes:type>episodic</itunes:type>
    <lastBuildDate>Sat, 19 Sep 2026 20:16:56 +0000</lastBuildDate>
    <item>
      <title>Start here: the high-yield walkthrough</title>
      <description>An orientation to the material that earns the most marks for the least time. What the written paper keeps coming back to, where candidates reliably lose marks, and how to use the rest of this series across a revision block.</description>
      <itunes:summary>An orientation to the material that earns the most marks for the least time. What the written paper keeps coming back to, where candidates reliably lose marks, and how to use the rest of this series across a revision block.</itunes:summary>
      <enclosure url="https://thamesuro.com/podcast/audio/FRCS_Pod_00_High_Yield_Walkthrough.mp3" length="8323722" type="audio/mpeg"/>
      <guid isPermaLink="false">thamesuro-frcs15-000-high-yield-walkthrough</guid>
      <pubDate>Sat, 20 Sep 2026 09:00:00 +0100</pubDate>
      <itunes:duration>23:05</itunes:duration>
      <itunes:episode>9</itunes:episode>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <link>https://thamesuro.com/podcast/</link>
    </item>
    <item>
      <title>Prostate cancer: grade groups, risk stratification and treatment decisions</title>
      <description>Screening and diagnosis, the mpMRI-first pathway and PI-RADS, biopsy routes, ISUP grade groups, risk stratification, and how localised, locally advanced and metastatic disease are actually managed. The single highest-yield topic in the exam.</description>
      <itunes:summary>Screening and diagnosis, the mpMRI-first pathway and PI-RADS, biopsy routes, ISUP grade groups, risk stratification, and how localised, locally advanced and metastatic disease are actually managed. The single highest-yield topic in the exam.</itunes:summary>
      <enclosure url="https://thamesuro.com/podcast/audio/FRCS_Pod_prostate_cancer.mp3" length="5839273" type="audio/mpeg"/>
      <guid isPermaLink="false">thamesuro-frcs15-001-prostate-cancer</guid>
      <pubDate>Sat, 20 Sep 2026 08:00:00 +0100</pubDate>
      <itunes:duration>16:11</itunes:duration>
      <itunes:episode>8</itunes:episode>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <link>https://thamesuro.com/podcast/</link>
    </item>
    <item>
      <title>Bladder cancer and upper tract TCC</title>
      <description>Haematuria workup, TURBT quality and re-resection, risk groups in non-muscle-invasive disease, BCG and what to do when it fails, radical cystectomy versus bladder preservation, and the separate logic of upper tract urothelial carcinoma.</description>
      <itunes:summary>Haematuria workup, TURBT quality and re-resection, risk groups in non-muscle-invasive disease, BCG and what to do when it fails, radical cystectomy versus bladder preservation, and the separate logic of upper tract urothelial carcinoma.</itunes:summary>
      <enclosure url="https://thamesuro.com/podcast/audio/FRCS_Pod_bladder_utuc.mp3" length="5801023" type="audio/mpeg"/>
      <guid isPermaLink="false">thamesuro-frcs15-002-bladder-utuc</guid>
      <pubDate>Fri, 19 Sep 2026 08:00:00 +0100</pubDate>
      <itunes:duration>16:05</itunes:duration>
      <itunes:episode>7</itunes:episode>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <link>https://thamesuro.com/podcast/</link>
    </item>
    <item>
      <title>Kidney and adrenal: the small renal mass and the incidentaloma</title>
      <description>Characterising a renal mass, the Bosniak system, when to biopsy, partial versus radical nephrectomy and active surveillance, the hereditary syndromes worth knowing cold, and a safe approach to the adrenal incidentaloma.</description>
      <itunes:summary>Characterising a renal mass, the Bosniak system, when to biopsy, partial versus radical nephrectomy and active surveillance, the hereditary syndromes worth knowing cold, and a safe approach to the adrenal incidentaloma.</itunes:summary>
      <enclosure url="https://thamesuro.com/podcast/audio/FRCS_Pod_kidney_adrenal.mp3" length="5804941" type="audio/mpeg"/>
      <guid isPermaLink="false">thamesuro-frcs15-003-kidney-adrenal</guid>
      <pubDate>Thu, 18 Sep 2026 08:00:00 +0100</pubDate>
      <itunes:duration>16:06</itunes:duration>
      <itunes:episode>6</itunes:episode>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <link>https://thamesuro.com/podcast/</link>
    </item>
    <item>
      <title>Stone disease: acute management to metabolic prevention</title>
      <description>Imaging the acute loin pain, when a stone needs decompressing tonight, medical expulsive therapy, choosing between ureteroscopy, shockwave lithotripsy and PCNL, and the metabolic work-up and prevention advice the exam expects you to give.</description>
      <itunes:summary>Imaging the acute loin pain, when a stone needs decompressing tonight, medical expulsive therapy, choosing between ureteroscopy, shockwave lithotripsy and PCNL, and the metabolic work-up and prevention advice the exam expects you to give.</itunes:summary>
      <enclosure url="https://thamesuro.com/podcast/audio/FRCS_Pod_stone_disease.mp3" length="5854205" type="audio/mpeg"/>
      <guid isPermaLink="false">thamesuro-frcs15-004-stone-disease</guid>
      <pubDate>Wed, 17 Sep 2026 08:00:00 +0100</pubDate>
      <itunes:duration>16:14</itunes:duration>
      <itunes:episode>5</itunes:episode>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <link>https://thamesuro.com/podcast/</link>
    </item>
    <item>
      <title>Testicular cancer: staging, markers and survivorship</title>
      <description>The lump in clinic, tumour markers and what they mean before and after orchidectomy, seminoma versus non-seminoma, staging and prognostic groups, adjuvant options and surveillance, plus fertility and the long-term consequences of treatment.</description>
      <itunes:summary>The lump in clinic, tumour markers and what they mean before and after orchidectomy, seminoma versus non-seminoma, staging and prognostic groups, adjuvant options and surveillance, plus fertility and the long-term consequences of treatment.</itunes:summary>
      <enclosure url="https://thamesuro.com/podcast/audio/FRCS_Pod_testicular_cancer.mp3" length="5569911" type="audio/mpeg"/>
      <guid isPermaLink="false">thamesuro-frcs15-005-testicular-cancer</guid>
      <pubDate>Tue, 16 Sep 2026 08:00:00 +0100</pubDate>
      <itunes:duration>15:27</itunes:duration>
      <itunes:episode>4</itunes:episode>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <link>https://thamesuro.com/podcast/</link>
    </item>
    <item>
      <title>BPH and male LUTS: assessment to intervention</title>
      <description>Assessing male lower urinary tract symptoms properly, what the flow rate and residual actually tell you, medical therapy and its trade-offs, and how to choose between TURP and the newer minimally invasive options when a patient wants to keep ejaculatory function.</description>
      <itunes:summary>Assessing male lower urinary tract symptoms properly, what the flow rate and residual actually tell you, medical therapy and its trade-offs, and how to choose between TURP and the newer minimally invasive options when a patient wants to keep ejaculatory function.</itunes:summary>
      <enclosure url="https://thamesuro.com/podcast/audio/FRCS_Pod_bph_luts.mp3" length="5708395" type="audio/mpeg"/>
      <guid isPermaLink="false">thamesuro-frcs15-006-bph-luts</guid>
      <pubDate>Mon, 15 Sep 2026 08:00:00 +0100</pubDate>
      <itunes:duration>15:50</itunes:duration>
      <itunes:episode>3</itunes:episode>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <link>https://thamesuro.com/podcast/</link>
    </item>
    <item>
      <title>Urological trauma: kidney, bladder and urethra</title>
      <description>Grading and managing renal trauma and when conservative management stops being safe, intraperitoneal versus extraperitoneal bladder rupture, the pelvic fracture urethral injury, and the emergencies that turn up in the viva as much as the paper.</description>
      <itunes:summary>Grading and managing renal trauma and when conservative management stops being safe, intraperitoneal versus extraperitoneal bladder rupture, the pelvic fracture urethral injury, and the emergencies that turn up in the viva as much as the paper.</itunes:summary>
      <enclosure url="https://thamesuro.com/podcast/audio/FRCS_Pod_trauma.mp3" length="5692220" type="audio/mpeg"/>
      <guid isPermaLink="false">thamesuro-frcs15-007-trauma</guid>
      <pubDate>Sun, 14 Sep 2026 08:00:00 +0100</pubDate>
      <itunes:duration>15:47</itunes:duration>
      <itunes:episode>2</itunes:episode>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <link>https://thamesuro.com/podcast/</link>
    </item>
    <item>
      <title>The last three days: what to revise when time has run out</title>
      <description>The cram episode. The numbers, staging tables and decision points worth holding in your head walking into the exam hall, and the things that are not worth another minute of your remaining time.</description>
      <itunes:summary>The cram episode. The numbers, staging tables and decision points worth holding in your head walking into the exam hall, and the things that are not worth another minute of your remaining time.</itunes:summary>
      <enclosure url="https://thamesuro.com/podcast/audio/FRCS_Pod_HighYield_Last3Days.mp3" length="5766487" type="audio/mpeg"/>
      <guid isPermaLink="false">thamesuro-frcs15-008-last-three-days</guid>
      <pubDate>Sat, 13 Sep 2026 08:00:00 +0100</pubDate>
      <itunes:duration>15:59</itunes:duration>
      <itunes:episode>1</itunes:episode>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <link>https://thamesuro.com/podcast/</link>
    </item>
  </channel>
</rss>
